Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-11

FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

The FDA approved Teva Respiratory's supplemental application for PROAIR DIGIHALER (albuterol sulfate), authorizing the supplemental action related to this inhal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProAir Digihaler (albuterol sulfate)

Snippet

SUPPL AP for PROAIR DIGIHALER (ALBUTEROL SULFATE)